NDC Package 63323-651-02 Adenosine

Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
63323-651-02
Package Description:
10 VIAL, SINGLE-USE in 1 TRAY / 2 mL in 1 VIAL, SINGLE-USE (63323-651-00)
Product Code:
Proprietary Name:
Adenosine
Non-Proprietary Name:
Adenosine
Substance Name:
Adenosine
Usage Information:
Intravenous adenosine injection is indicated for the following:Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome).  When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine injection administration.It is important to be sure the adenosine injection solution actually reaches the systemic circulation (see DOSAGE AND ADMINISTRATION). Adenosine injection does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm.  In the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine injection administration.
11-Digit NDC Billing Format:
63323065102
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1654035 - adenosine 60 MG in 20 mL Injection
  • RxCUI: 1654035 - 20 ML adenosine 3 MG/ML Injection
  • RxCUI: 1654035 - adenosine 60 MG per 20 ML Injection
  • RxCUI: 1654040 - adenosine 90 MG in 30 mL Injection
  • RxCUI: 1654040 - 30 ML adenosine 3 MG/ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Fresenius Kabi Usa, Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
  • Sample Package:
    No
    FDA Application Number:
    ANDA077897
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    11-27-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 63323-651-02 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    63323065102J0153Adenosine inj 1mg1 MG210660

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    63323-651-0410 VIAL, SINGLE-USE in 1 TRAY / 4 mL in 1 VIAL, SINGLE-USE (63323-651-01)
    63323-651-201 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE
    63323-651-301 VIAL, SINGLE-DOSE in 1 CARTON / 30 mL in 1 VIAL, SINGLE-DOSE
    63323-651-8910 SYRINGE, PLASTIC in 1 CARTON / 2 mL in 1 SYRINGE, PLASTIC (63323-651-21)
    63323-651-9010 SYRINGE, PLASTIC in 1 CARTON / 4 mL in 1 SYRINGE, PLASTIC (63323-651-23)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 63323-651-02?

    The NDC Packaged Code 63323-651-02 is assigned to a package of 10 vial, single-use in 1 tray / 2 ml in 1 vial, single-use (63323-651-00) of Adenosine, a human prescription drug labeled by Fresenius Kabi Usa, Llc. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 63323-651 included in the NDC Directory?

    Yes, Adenosine with product code 63323-651 is active and included in the NDC Directory. The product was first marketed by Fresenius Kabi Usa, Llc on November 27, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 63323-651-02?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 63323-651-02?

    The 11-digit format is 63323065102. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-263323-651-025-4-263323-0651-02